Quarterly report pursuant to Section 13 or 15(d)

Nature of Operations and Summary of Significant Accounting and Reporting Policies - Schedule of Dilutive Securities Excluded from Computation (Details)

v3.20.2
Nature of Operations and Summary of Significant Accounting and Reporting Policies - Schedule of Dilutive Securities Excluded from Computation (Details) - shares
3 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Antidilutive securities excluded from computation of earnings per share 646,575,560 5,241,468
Stock Options [Member]    
Antidilutive securities excluded from computation of earnings per share 59,644 59,644
Stock Warrants [Member]    
Antidilutive securities excluded from computation of earnings per share 135,725,000 975,059
Restricted Stock to be Issued [Member]    
Antidilutive securities excluded from computation of earnings per share 117,000 117,000
Convertible Debt [Member]    
Antidilutive securities excluded from computation of earnings per share 510,673,916 4,089,765